Analysts: AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

9.05USD
2 Mar 2015
Change (% chg)

$0.19 (+2.14%)
Prev Close
$8.86
Open
$8.86
Day's High
$9.11
Day's Low
$8.83
Volume
193,991
Avg. Vol
359,748
52-wk High
$13.64
52-wk Low
$5.22

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.30 December 2 Mar 2015

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 4 3 3 3
(3) HOLD 3 4 4 4
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.11 2.22 2.22 2.22

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 6 0.05 0.27 0.00 --
Quarter Ending Jun-15 6 4.55 15.00 0.00 --
Year Ending Dec-15 9 12.39 25.10 0.00 52.43
Earnings (per share)
Quarter Ending Mar-15 4 -0.30 -0.28 -0.32 --
Quarter Ending Jun-15 4 -0.24 -0.05 -0.33 --
Year Ending Dec-15 9 -1.04 -0.76 -1.29 -0.28

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-14 4.44 4.82 0.39 8.78
Quarter Ending Jun-14 0.04 0.07 0.03 59.91
Quarter Ending Mar-14 0.08 0.09 0.01 18.16
Quarter Ending Dec-13 4.93 0.24 4.69 95.19
Quarter Ending Sep-13 0.34 0.55 0.21 59.81
Earnings (per share)
Quarter Ending Sep-14 -0.22 -0.13 0.09 -41.78
Quarter Ending Jun-14 -0.26 -0.24 0.02 -8.85
Quarter Ending Mar-14 -0.23 -0.22 0.01 -3.30
Quarter Ending Dec-13 -0.17 -0.20 0.03 -15.41
Quarter Ending Sep-13 -0.19 -0.26 0.07 -33.81

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 0.05 0.05 0.05 0.05 --
Quarter Ending Jun-15 4.55 4.55 4.55 4.55 --
Year Ending Dec-15 12.39 12.39 12.39 12.39 52.43
Earnings (per share)
Quarter Ending Mar-15 -0.30 -0.30 -0.30 -0.30 --
Quarter Ending Jun-15 -0.24 -0.24 -0.24 -0.24 --
Year Ending Dec-15 -1.04 -1.04 -1.04 -1.04 -0.28

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-15 0 0 0 0
Quarter Ending Jun-15 0 0 0 0
Year Ending Dec-15 0 0 0 0
Earnings
Quarter Ending Mar-15 0 0 0 0
Quarter Ending Jun-15 0 0 0 0
Year Ending Dec-15 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: TheStreet.com Ratings
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks